| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/0961203317703494 |
| P698 | PubMed publication ID | 28399687 |
| P2093 | author name string | J Li | |
| S Kapoor | |||
| T M Kapoor | |||
| A Askanase | |||
| J Bathon | |||
| J Giles | |||
| P Mahadeshwar | |||
| S Nguyen | |||
| P2860 | cites work | Measuring diagnoses: ICD code accuracy | Q24537540 |
| Current epidemiology of Pneumocystis pneumonia | Q28289603 | ||
| The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
| Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 | ||
| Effects of chloroquine on viral infections: an old drug against today's diseases? | Q33973620 | ||
| Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis | Q35655534 | ||
| National Lupus Hospitalization Trends Reveal Rising Rates of Herpes Zoster and Declines in Pneumocystis Pneumonia | Q35885259 | ||
| Infections and SLE. | Q36350798 | ||
| Pneumocystis pneumonia in patients treated with rituximab | Q36411232 | ||
| Reactions of quinine, chloroquine, and quinacrine with DNA and their effects on the DNA and RNA polymerase reactions | Q36460497 | ||
| Undertreatment of disease activity in systemic lupus erythematosus patients with endstage renal failure is associated with increased all-cause mortality | Q37176237 | ||
| Prophylactic antibiotic usage for Pneumocystis jirovecii pneumonia in patients with systemic lupus erythematosus on cyclophosphamide: a survey of US rheumatologists and the review of literature | Q37234955 | ||
| Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies | Q37629055 | ||
| Update on the diagnosis and treatment ofPneumocystispneumonia | Q37782191 | ||
| Hydroxychloroquine: from malaria to autoimmunity | Q37827403 | ||
| Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past | Q38008702 | ||
| Healthcare utilization and comorbidity burden among children and young adults in the United States with systemic lupus erythematosus or inflammatory bowel disease | Q38009468 | ||
| Update on pulmonary Pneumocystis jirovecii infection in non-HIV patients | Q38196066 | ||
| Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality | Q39499935 | ||
| KDIGO clinical practice guideline for the care of kidney transplant recipients | Q39936865 | ||
| Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus | Q41364293 | ||
| Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine | Q41924708 | ||
| The antiinflammatory and antiviral effects of hydroxychloroquine in two patients with acquired immunodeficiency syndrome and active inflammatory arthritis | Q41931925 | ||
| Chloroquine and primaquine inhibition of rat liver cell-free polynucleotide-dependent polypeptide synthesis | Q41935778 | ||
| Chloroquine: mode of action | Q41942231 | ||
| DNA: Reaction with Chloroquine | Q41942580 | ||
| Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus | Q41977234 | ||
| Quinacrine enhances vesicular stomatitis virus inactivation and diminishes hemolysis of dimethylmethylene blue-phototreated red cells | Q44236552 | ||
| Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus | Q44489164 | ||
| Pneumocystis carinii carriage in immunocompromised patients with and without human immunodeficiency virus infection | Q45731664 | ||
| Mycophenolate mofetil may protect against Pneumocystis carinii pneumonia in renal transplanted patients | Q46602104 | ||
| New insights into the antiviral effects of chloroquine. | Q46913485 | ||
| Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. HLA Task Force of the Kidney Advisory Group of the United Kingdom Transplant Support Service Authority (UKTSSA) | Q50142689 | ||
| Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real-Life, International Systemic Lupus Erythematosus C | Q51064225 | ||
| A scoring system to screen elderly potential kidney transplant recipients: a simple tool for a complex task. | Q53637358 | ||
| Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates. | Q54492149 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| pneumonia | Q12192 | ||
| data warehouses | Q193351 | ||
| P304 | page(s) | 961203317703494 | |
| P577 | publication date | 2017-01-01 | |
| P1433 | published in | Lupus | Q6704846 |
| P1476 | title | Low prevalence of Pneumocystis pneumonia in hospitalized patients with systemic lupus erythematosus: review of a clinical data warehouse |
| Q89635103 | Hydroxychloroquine may reduce risk of Pneumocystis pneumonia in lupus patients: a Nationwide, population-based case-control study | cites work | P2860 |
Search more.